ClinicalTrials.gg

Cascadian Therapeutics Inc. clinical trials

Acquired by Pfizer, Dec 14, 2023 · source ↗

The registry lists 12 studies whose lead sponsor is Cascadian Therapeutics Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 29, 2018.

Before and after it joined Pfizer

First submitted before Cascadian Therapeutics Inc. became part of Pfizer
12
First submitted after Cascadian Therapeutics Inc. became part of Pfizer
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Cascadian Therapeutics Inc.’s studies test, most studies first; none is open now — 5 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 12 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed1083%
  • Stopped early217%

Phase

  • Phase 111
  • Phase 24

Where

  • United States12
  • Canada2

Over the years

  1. 07
  2. 208
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 026

By the year each study started; 1 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Cascadian Therapeutics Inc.12 studies

Something wrong with this grouping? Tell us on the Pfizer page.

Studies

Recruiting first, then most recently updated. Showing 12 of 12. All Pfizer studies →